CPPs to the Test: Effects on Binding, Uptake and Biodistribution of a Tumor Targeting Nanobody
Nanobodies are well-established targeting ligands for molecular imaging and therapy. Their short circulation time enables early imaging and reduces systemic radiation exposure. However, shorter circulation time leads to lower tracer accumulation in the target tissue. Cell-penetrating peptides (CPPs)...
Saved in:
Main Authors: | Estel Collado Camps (Author), Sanne A. M. van Lith (Author), Cathelijne Frielink (Author), Jordi Lankhof (Author), Ingrid Dijkgraaf (Author), Martin Gotthardt (Author), Roland Brock (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanobody
Published: (2021) -
Cell Penetrating Peptides (CPPs): A new era for localised drug delivery
by: Myasar Mohammed Alkotaji
Published: (2023) -
NbX: Machine Learning-Guided Re-Ranking of Nanobody-Antigen Binding Poses
by: Chunlai Tam, et al.
Published: (2021) -
Enhanced tumor uptake, biodistribution and pharmacokinetics of etoposide loaded nanoparticles in Dalton's lymphoma tumor bearing mice
by: Movva Snehalatha, et al.
Published: (2013) -
Implementing standardized cancer patient pathways (CPPs) - a qualitative study exploring the perspectives of health care professionals
by: Sara Delilovic, et al.
Published: (2019)